Standard Family Office LLC Horizon Therapeutics Public LTD CO Transaction History

Standard Family Office LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $73,365 - $107,516	924 New	924 $74,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $106,728 - $135,615	-1,235 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $121,721 - $148,088	1,235 New	1,235 $133,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $142,736 - $171,404	-1,553 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $104,051 - $131,057	1,553 New	1,553 $114,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.